Quick Asked: Crescendo Biologics Limited Contact Us?
Last update: 12 Apr, 2024 
245 Views
What is crescendo biologics? Crescendo Biologics is engaged in the development of a proprietary drug portfolio based on their VH antibody fragment platform. Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.Who are crescendos investors? Located in Cambridge, UK, Crescendo is backed by blue-chip investors including Sofinnova Partners, Andera Partners, IP Group plc, Takeda and Quan Capital.Where is crescendo located? Crescendo’s premises are located in the Meditrina Building, also known as Building 260. From central Cambridge: Take the A1307 signposted to Haverhill, past Addenbrookes Hospital. Babraham is located a further 3 miles (5km) outside of Cambridge, approximately 6 miles south east of the city centre.What is crescendos strategic collaboration with takeda? Crescendo has a global, strategic, multi-target collaboration in immuno-oncology, ADCs and CAR-Ts with Takeda, worth up to $790M.
Listing Results Crescendo Biologics Limited Contact Us? Question Answers
Board Crescendo Biologics
He is currently chairman of Crescendo Biologics Ltd., Levicept Ltd. and Apcintex as well as being a board member of several other startups. Prior to joining Index, Kevin was with Cambridge Antibody Technology (CAT), where he was appointed Head of Research in 1994 and, in 1997, Research Director and Chief Technology Officer.